StocksHikma Pharmaceuticals PLCHIK.L

HIK.L

Hikma Pharmaceuticals PLC

1443.70 -52.45 (-3.51%)
Prices By Xignite, in GBX Market Closed
Trade
S
1443.70
B
1447.30

Overview

Prev Close1443.70
Day's Range 1437.21 - 1473.67
52 Week Range 1437.21 - 2621.64
Average Volume (3m)529.41K
1-Year Return-43.49%
Beta0.0776
Market Cap2.99B
P/E Ratio12.67
Revenue1.92B
EPS1.1376
Dividend (Yield)0.431363 (2.99%)
1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max
Chart times in UTC
Industry Pharmaceuticals Generic
CEO Said Samih Taleb Darwazah, MBA
Employees 8,700

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2021: Hikma Pharmaceuticals PLC's revenues increased by 1.69% and amounted to 1.86B. Net income decreased by 8.93% to 305.39M. Net assets increased by 15.91% to 1.82B and EPS decreased from 1.41 to 1.31.
HIK.L's Investor Relations
Income StatementBalance SheetCash Flow Statement
Gross Margin
47.27%
Net Profit Margin
5.40%
Operating Margin
21.79%
Return On Investment
4.68%
2018
2019
2020
2021
Total Revenue
1.56B
1.73B
1.83B
1.86B
Gross Profit
764.21M
876.35M
892.11M
892.89M
Operating Income
365.23M
416.23M
435.14M
434.09M
Net Income
213.74M
381.74M
335.32M
305.39M